Jump to Navigation
Trends and Sentiments
Comments and Analysis
Now Scorpio Bulkers Drops A Signal Of An Impending...
Apollo Education Group's (APOL) CEO Greg Cappelli on...
Explainer: Greece’s IMF payment
Events Continue To Conspire Against The Fed
Ford Vs. GM: From A Dividend, Free Cash Flow (And...
Euro Manipulation - I Feel Dirty
Chicken Little? Chicken Who? Who's Chicken? Not Us...
Australia 200 Slumps To 5-Month Low Below 5400
Google Translate gets more conversational
End Of A Streak?
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
Consumer confidence jumps to highest in 15 years
Aboriginal experience inspires artist Abramovic...
EUR/GBP: 1.4046 USD/EUR: 1.1194 JPY/USD: 122.3050
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions